ActiveSC760230Private limited companyGlasgow

GLOX THERAPEUTICS LIMITED

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Glox Therapeutics Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Glox Therapeutics Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

GLOX THERAPEUTICS LIMITED is an active private limited company (company number SC760230) incorporated on 27 February 2023, registered in Glasgow. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (small) but not yet parsed into this record.

There are 2,418 companies in research and experimental development on biotechnology in the UK with filed accounts; the median reports net assets of £1,000 and is 7 years old.

Ownership and control

0 active · 4 other

No active person with significant control is registered.

persons with significant control statement · since 20 November 2024
G U Holdings Limited
corporate entity, United Kingdom · since 27 February 2023 · ceased 12 April 2023
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
75–100%
PC
Professor Colin Kleanthous
Individual · since 12 April 2023 · ceased 13 April 2023
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
PD
Professor Daniel Walker
Individual · since 12 April 2023 · ceased 24 October 2023
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 27 February 20233 yrs ago
First accounts due: 27 November 2024699 days overdue
Confirmation statement due: 13 March 2027in 137 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
SIC 72190: Other research and experimental development on natural sciences and engineering
Accounts type: Small

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated two to five years agoIncorporated 27 February 2023
Accounts past their due dateDue 27 November 2024

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

13 Mar 2027Confirmation statement duein 137 days
27 Nov 2024First accounts due699 days overdue
27 Feb 2023Incorporated

Similar companies in Glasgow

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 27 February 2023 · in Feb 2023.

Reminders for GLOX THERAPEUTICS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.